Platelets and coronary disease, round three.
作者信息
Hampton J R
出版信息
Br Med J (Clin Res Ed). 1985 Feb 9;290(6466):414-5. doi: 10.1136/bmj.290.6466.414.
Abstract
摘要
相似文献
1
Platelets and coronary disease, round three.血小板与冠状动脉疾病，第三轮探讨。
Br Med J (Clin Res Ed). 1985 Feb 9;290(6466):414-5. doi: 10.1136/bmj.290.6466.414.
2
Platelet function tests and coronary heart disease.血小板功能测试与冠心病
Adv Exp Med Biol. 1984;164:31-47. doi: 10.1007/978-1-4684-8616-2_4.
3
The platelet and coronary artery disease.血小板与冠状动脉疾病。
Ser Haematol. 1975;8(3):125-140.
4
[Coronary artery thrombosis, cerebral artery thrombosis and platelet functions].[冠状动脉血栓形成、脑动脉血栓形成与血小板功能]
Nihon Rinsho. 1978 Dec 10;36(12):3863-9.
5
[Properties of thrombocytes in patients with ischemic heart disease].[缺血性心脏病患者血小板的特性]
Vrach Delo. 1987 Apr(4):39-41.
6
Platelet function in coronary artery disease.冠状动脉疾病中的血小板功能
J Lab Clin Med. 1971 Nov;78(5):807.
7
[The importance of platelet function for the detection of thrombosis susceptibliity].[血小板功能在检测血栓形成易感性中的重要性]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1975;102(2):212-9.
8
Haemostatic function in coronary artery disease (CAD).冠状动脉疾病（CAD）中的止血功能。
Indian J Pathol Microbiol. 1997 Apr;40(2):133-7.
9
[Changes in the coagulation and fibrinolytic system after hyperthermia in healthy and ill subjects].[健康和患病受试者热疗后凝血和纤溶系统的变化]
Fysiatr Revmatol Vestn. 1982 Dec;60(6):350-6.
10
[Activation of platelets in pathological processes].[病理过程中血小板的激活]
Sheng Li Ke Xue Jin Zhan. 1987 Apr;18(2):166-8.
引用本文的文献
1
Determinants of ADP-induced platelet aggregation in diabetes mellitus.糖尿病中ADP诱导的血小板聚集的决定因素。
Diabetologia. 1986 May;29(5):291-4. doi: 10.1007/BF00452065.
本文引用的文献
1
POSTOPERATIVE CHANGES IN PLATELET-CLUMPING ACTIVITY.
Lancet. 1965 Jan 9;1(7376):71-5. doi: 10.1016/s0140-6736(65)91655-7.
2
Aggregation of blood platelets by adenosine diphosphate and its reversal.二磷酸腺苷引起的血小板聚集及其逆转
Nature. 1962 Jun 9;194:927-9. doi: 10.1038/194927b0.
3
Platelet-release reaction in myocardial infarction.心肌梗死中的血小板释放反应。
Br Med J. 1980 Jan 12;280(6207):80-1. doi: 10.1136/bmj.280.6207.80.
4
Plasma beta-thromboglobulin as a measure of platelet activity. Effect of risk factors and findings in ischemic heart disease and after acute myocardial infarction.血浆β-血小板球蛋白作为血小板活性的一项指标。缺血性心脏病及急性心肌梗死后危险因素和研究结果的影响
Am J Cardiol. 1982 Dec;50(6):1258-61. doi: 10.1016/0002-9149(82)90459-3.
5
Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.低剂量阿司匹林对人静脉前列环素合成和血小板血栓素合成的差异性抑制作用。
Lancet. 1981 May 2;1(8227):969-71. doi: 10.1016/s0140-6736(81)91733-5.
6
Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.心脏瓣膜置换术后血栓栓塞并发症的药物控制。初步报告。
N Engl J Med. 1968 Sep 12;279(11):576-80. doi: 10.1056/NEJM196809122791104.
7
Platelet studies in patients with coronary artery disease and in their relatives.冠状动脉疾病患者及其亲属的血小板研究。
Br Heart J. 1972 May;34(5):465-71. doi: 10.1136/hrt.34.5.465.
8
A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.一项关于乙酰水杨酸在心肌梗死死亡率二级预防中的随机对照试验。
Br Med J. 1974 Mar 9;1(5905):436-40. doi: 10.1136/bmj.1.5905.436.
9
10
Aspirin and secondary mortality after myocardial infarction.
Lancet. 1979;2(8156-8157):1313-5. doi: 10.1016/s0140-6736(79)92808-3.
Zotero 插件